SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kintara Therapeutics, Inc. 
 CA
  SEC # 1498382


        
1  Related Registrant:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

169  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
10/27/23S-1/A1About This Prospectus
9/19/23424B51About This Prospectus Supplement
1Additional Information
9/18/2310-K1Business
10/27/23S-1/A1Capitalization
1Cautionary Note Regarding Forward Looking Statements
9/19/23424B51Cautionary Note Regarding Forward-Looking Statements
9/18/2310-K1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
2/14/2410-Q1Controls and Procedures
1Defaults Upon Senior Securities
9/19/23424B51Description of Capital Stock
1Description of Debt Securities
1Description of Stock Warrants
1Description of Subscription Rights
10/27/23S-1/A1Description of the Capital Stock
1Description of the Securities We Are Offering
9/19/23424B51Description of Units
10/27/23S-1/A1Dilution
9/18/2310-K1Directors, Executive Officers, and Corporate Governance
9/19/23424B51Disclosure of Commission Position on Indemnification for Securities Act Liabilities
9/18/2310-K1Disclosure Regarding Foreign Jurisdictions Preventing Inspections
1Executive Compensation
2/14/2410-Q1Exhibits
10/27/23S-1/A1Experts
2/14/2410-Q1Financial Information
1Financial Statements
9/18/2310-K1Financial Statements and Supplementary Data
1Form 10-K Summary
9/19/23424B51Forms of Securities
1Forward-Looking Statements
10/27/23S-1/A1Incorporation of Certain Information by Reference
9/18/2310-K1Item 1
1Item 10
1Item 11
1Item 12
1Item 13
1Item 14
1Item 15
1Item 16
1Item 1A
1Item 1B
1Item 2
1Item 3
1Item 4
1Item 5
1Item 6
1Item 7
1Item 7A
1Item 8
1Item 9
1Item 9A
1Item 9B
1Item 9C
10/27/23S-1/A1Legal Matters
2/14/2410-Q1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
9/18/2310-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
10/27/23S-1/A1Market Price of Our Common Stock
2/14/2410-Q1Mine Safety Disclosures
10/27/23S-1/A1Offering, The
2/14/2410-Q1Other Information
9/18/2310-K1Part I
2/14/2410-Q1Part I. -- Financial Information
9/18/2310-K1Part Ii
2/14/2410-Q1Part Ii -- Other Information
9/18/2310-K1Part Iii
1Part Iv
10/27/23S-1/A1Plan of Distribution
9/18/2310-K1Principal Accountant Fees and Services
1Properties
10/27/23S-1/A1Prospectus Summary
9/19/23424B51Prospectus Supplement Summary
2/14/2410-Q1Quantitative and Qualitative Disclosures About Market Risk
9/18/2310-K1Reserved
2/14/2410-Q1Risk Factors
9/19/23424B51Securities We May Offer, The
9/18/2310-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
1Signatures
10/27/23S-1/A1The Offering
9/19/23424B51The Securities We May Offer
5/11/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
2/14/2410-Q1Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
9/18/2310-K1Unresolved Staff Comments
10/27/23S-1/A1Use of Proceeds
1Where You Can Find More Information

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 11:48:33.2am ET